-
International Journal of Chronic Obstructive Pulmonary Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Tissue regeneration as next-generation therapy for COPD – potential applications
Review
(2831) Views (5025) Full article downloads
Authors: Shunsuke Ohnishi, Noritoshi Nagaya
Published Date August 2008
Volume 2008:3(4) Pages 509 - 514
DOI: http://dx.doi.org/10.2147/COPD.S1092
Shunsuke Ohnishi, Noritoshi Nagaya
Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Suita, Osaka, Japan
Abstract: COPD is a major cause of chronic morbidity and mortality worldwide, and there is a need to develop more effective therapeutic strategies to replace specialized treatment such as lung transplantation. Recent studies suggest that recognition of apoptotic lung epithelial or endothelial cells may result in growth factors to stimulate cell replacement, and defects in these processes may contribute to the pathogenesis of COPD. Furthermore, recent animal and human studies have revealed that tissue-specific stem cells and bone marrow-derived cells contribute to lung tissue regeneration and protection, and thus administration of exogenous stem/progenitor cells or humoral factors responsible for activation of endogenous stem/progenitor cells may be a potent next-generation therapy for COPD.
Keywords: COPD, regenerative medicine, cell therapy, stem cell, bone marrow, growth factor
Readers of this article also read:
Noninvasive ventilation in patients with chronic obstructive airway disease
Chronic respiratory effect of narguileh smoking compared with cigarette smoking in women from the East Mediterranean region
Mechanisms of improvement of respiratory failure in patients with COPD treated with NIV
Preferential recruitment of neutrophils by endothelin-1 in acute lung inflammation induced by lipopolysaccharide or cigarette smoke
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
The pathophysiology of bronchiectasis
Potential role of stem cells in management of COPD
Budesonide/formoterol combination in COPD: a US perspective
Development and implementation of treadmill exercise testing protocols in COPD
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




